In vivo Bruton’s tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis | Science Translational Medicine

Pharmacological inhibition of BTK attenuates alcohol-induced granulopoiesis and neutrophil-mediated liver damage in a preclinical model of alcohol-associated hepatitis.